» Articles » PMID: 12621119

Iron Deficiency Alters Iron Regulatory Protein and Iron Transport Protein Expression in the Perinatal Rat Brain

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2003 Mar 7
PMID 12621119
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Iron plays an important role in numerous vital enzyme systems in the perinatal brain. The membrane proteins that mediate iron transport [transferrin receptor (TfR) and divalent metal transporter 1 (DMT-1)] and the iron regulatory proteins (IRP-1 and IRP-2) that stabilize their mRNAs undergo regional developmental changes in the iron-sufficient rat brain between postnatal day (P) 5 and 15. Perinatal iron deficiency (ID) affects developing brain regions nonhomogeneously, suggesting potential differences in regional iron transporter and regulatory protein expression. The objective of the study was to determine the effect of perinatal ID on regional expression of IRP-1, IRP-2, TfR, and DMT-1 in the developing rat brain. Gestationally iron-deficient Sprague Dawley rat pups were compared with iron-sufficient control pups at P10. Serial 12-mu coronal sections of fixed frozen brain from pups on P10 were assessed by light microscopy for IRP-1, IRP-2, DMT-1, and TfR localization. ID did not change the percentage of cells with positive staining for the four proteins in the choroid epithelium, ependyma, vascular endothelium, or neurons of the striatum. ID increased the percentage of neurons expressing the four proteins in the hippocampus and the cerebral cortex. Increased numbers of TfR- and DMT-1-positive cells were always associated with increased IRP-positive cells. The P10 rat responds to perinatal ID by selectively increasing the number of neurons expressing IRP-regulated transporters in brain regions that are rapidly developing, without any change at transport surfaces or in regions that are quiescent. Brain iron distribution during ID seems to be locally rather than globally regulated.

Citing Articles

Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease-Postmortem ICP-MS Analysis of Selected Human Tissues.

Baj J, Kowalska B, Barbachowska A, Forma A, Flieger M, Majerek D Nutrients. 2023; 15(15).

PMID: 37571395 PMC: 10420647. DOI: 10.3390/nu15153458.


Brain Iron Metabolism, Redox Balance and Neurological Diseases.

Gao G, You L, Zhang J, Chang Y, Yu P Antioxidants (Basel). 2023; 12(6).

PMID: 37372019 PMC: 10294882. DOI: 10.3390/antiox12061289.


Regulation of brain iron uptake by apo- and holo-transferrin is dependent on sex and delivery protein.

Baringer S, Neely E, Palsa K, Simpson I, Connor J Fluids Barriers CNS. 2022; 19(1):49.

PMID: 35689283 PMC: 9188189. DOI: 10.1186/s12987-022-00345-9.


The Potential Roles of Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier in Maintaining Brain Manganese Homeostasis.

McCabe S, Zhao N Nutrients. 2021; 13(6).

PMID: 34072120 PMC: 8227615. DOI: 10.3390/nu13061833.


Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low-grade haemolysis of fragile macrocytic red blood cells.

Wimmer I, Scharler C, Kadowaki T, Hillebrand S, Scheiber-Mojdehkar B, Ueda S Brain Pathol. 2020; 31(2):333-345.

PMID: 33220123 PMC: 8018038. DOI: 10.1111/bpa.12920.